All In Biotech

Drug Trial Radar · NCT07161700

An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults With Major Depressive Disorder, With or Without Anxious Distress

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

360

Planned (sponsor's estimate)

Start

Sep 2, 2025

Primary completion

May 2027

Study completion May 2027

Sponsor

Lead sponsor
Seaport TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Premier Research
First posted
Sep 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 66 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, monotherapy, extension study to evaluate the safety and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.

Conditions

  • Major Depressive Disorder (MDD)
  • Major Depressive Disorder With Anxious Distress

Interventions

  • SPT-300Drug

    A prodrug of allopregnanolone, a small molecule drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability assessments based on Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and validated clinical scales and proceduresTime frame: Up to Day 49

Locations

46 sites in 7 countries. Site status is shown where the registry gives one.

  • Seaport Investigator Site

    Chino, California

  • Seaport Investigator Site

    Garden Grove, California

  • Seaport Investigator Site

    Glendale, California

  • Seaport Investigator Site

    San Jose, California

  • Seaport Investigator Site

    Cromwell, Connecticut

  • Seaport Investigator Site

    Lauderhill, Florida

  • Seaport Investigator Site

    Palm Bay, Florida

  • Seaport Investigator Site

    West Palm Beach, Florida

  • Seaport Investigator Site

    Atlanta, Georgia

  • Seaport Investigator Site

    Decatur, Georgia

  • Seaport Investigator Site

    Boston, Massachusetts

  • Seaport Investigator Site

    St Louis, Missouri

  • Seaport Investigator Site

    Brooklyn, New York

  • Seaport Investigator Site

    Cedarhurst, New York

  • Seaport Investigator Site

    New York, New York

  • Seaport Investigator Site

    Staten Island, New York

  • Seaport Investigator Site

    Independence, Ohio

  • Seaport Investigator Site

    North Canton, Ohio

  • Seaport Investigator Site

    Dallas, Texas

  • Seaport Investigator Site

    Irving, Texas

  • Seaport Investigator Site

    Richardson, Texas

  • Seaport Investigator Site

    Everett, Washington

  • Seaport Investigator Site

    Lovech, Bulgaria

  • Seaport Investigator Site

    Plovdiv, Bulgaria

  • Seaport Investigator Site

    Sofia, Bulgaria

  • Seaport Investigator Site

    Brno, Czechia

  • Seaport Investigator Site

    Pilsen, Czechia

  • Seaport Investigator Site

    Prague, Czechia

  • Seaport Investigator Site

    Prague, Czechia

  • Seaport Investigator Site

    Prague, Czechia

  • Seaport Investigator Site

    Prague, Czechia

  • Seaport Investigator Site

    Bad Homburg, Germany

  • Seaport Investigator Site

    Chemnitz, Germany

  • Seaport Investigator Site

    Berlin, Brandenburg, Germany

  • Seaport Investigator Site

    Schwerin, Mecklenburg-Vorpommern, Germany

  • Seaport Investigator Site

    Budapest, Hungary

  • Seaport Investigator Site

    Budapest, Hungary

  • Seaport Investigator Site

    Bialystok, Poland

  • Seaport Investigator Site

    Bialystok, Poland

  • Seaport Investigator Site

    Bydgoszcz, Poland

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.